Clinical trial
Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox…
NCT00466570 · Stanford University, Other · Withdrawn
Key facts
| NCT number | NCT00466570 |
|---|---|
| Title | Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour Application |
| Official title | Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour |
| Lead sponsor | Stanford University, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Conjunctical Flora |
| Intervention type | Drug |
| Interventions | gatifloxacin, moxifloxacin |
| Enrollment | 0 |
| Start date | Apr 1, 2007 |
| First posted | Apr 27, 2007 |
| Last update posted | Jun 13, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: